Although a vaccine is available for meningococcus, it is still difficult at this time to produce a vaccine for the type B organism, the most common one in the United States.
The diagnosis of meningococcemia can be made by the growth of the organism from blood cultures.
Immediate treatment of a suspected case of meningococcemia begins with antibiotics that work against the organism.
As many as 15-20% of patients with meningococcemia will die as a result of the acute infection.
ccccccrrraaazzzzyyy!!!!!!!!!!!!!!!u are veeerrryyyyyy!!!!!!!!!!!!!
sa puso mo
You can find reading material on meningococcemia in medical textbooks, journal articles, and reputable websites such as the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO). These sources will provide information on symptoms, diagnosis, treatment, and prevention of meningococcemia.
Yes
No. It would be quite unusual for this to happen.
Certain people with immune system defects (particularly those with defects in the complement system) may have recurrent episodes of meningococcemia. These patients, however, seem to have a less serious outcome.
The first signs of the infection's severity are small bleeding spots seen on the skin (petechiae). A doctor should always suspect meningococcemia when he/she finds an acutely ill patient with fever, chills, and petechiae.
It is most likely that the speed of initial treatment will affect the ultimate outcome.
A significant percentage of the survivors will have tissue damage that requires surgical treatment.